LENZ
LENZ Therapeutics Inc
4.10$
-1.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | -100.0% | – | – | |
| – | – | +506.6% | +1,037.1% | -71.2% | -97.6% | +1,115.5% | |
| – | – | – | – | -116.0% | – | – | |
| – | – | +315.8% | -44.3% | +181.7% | -49.9% | -37.4% | |
| – | – | – | +76.2% | +196.6% | +122.9% | +216.4% | |
| – | +46,034.5% | +346.3% | -57.3% | +184.2% | -19.2% | +87.0% | |
| – | – | – | – | – | – | – | |
| – | -50.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | -30.2% | -151.6% | – | +50,100.0% | |
| – | – | – | – | – | – | – | |
| – | -47,847.4% | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.